These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 28953989)

  • 1. Collaborative care model improves self-care ability, quality of life and cardiac function of patients with chronic heart failure.
    Hua CY; Huang Y; Su YH; Bu JY; Tao HM
    Braz J Med Biol Res; 2017 Sep; 50(11):e6355. PubMed ID: 28953989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of amino-terminal pro-B-type natriuretic peptide to guide outpatient therapy of patients with chronic left ventricular systolic dysfunction.
    Januzzi JL; Rehman SU; Mohammed AA; Bhardwaj A; Barajas L; Barajas J; Kim HN; Baggish AL; Weiner RB; Chen-Tournoux A; Marshall JE; Moore SA; Carlson WD; Lewis GD; Shin J; Sullivan D; Parks K; Wang TJ; Gregory SA; Uthamalingam S; Semigran MJ
    J Am Coll Cardiol; 2011 Oct; 58(18):1881-9. PubMed ID: 22018299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prognostic value of repeated measurement of N-terminal pro-B-type natriuretic peptide in patients with chronic heart failure due to left ventricular systolic dysfunction.
    Kubánek M; Goode KM; Lánská V; Clark AL; Cleland JG
    Eur J Heart Fail; 2009 Apr; 11(4):367-77. PubMed ID: 19179406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pro-brain natriuretic peptide plasma levels, left ventricular dimensions and ejection fraction in acute dyspnoea.
    Shaikh K; Hanif B; Siddique AA; Shaikh MY; Khan MN
    J Coll Physicians Surg Pak; 2012 Dec; 22(12):751-5. PubMed ID: 23217478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Sacubitril/Valsartan vs Standard Medical Therapies on Plasma NT-proBNP Concentration and Submaximal Exercise Capacity in Patients With Heart Failure and Preserved Ejection Fraction: The PARALLAX Randomized Clinical Trial.
    Pieske B; Wachter R; Shah SJ; Baldridge A; Szeczoedy P; Ibram G; Shi V; Zhao Z; Cowie MR;
    JAMA; 2021 Nov; 326(19):1919-1929. PubMed ID: 34783839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cutoff values of NT-proBNP for the prediction of low functional capacity, decreased ejection fraction and cardiovascular events in patients with heart failure.
    Koç M; Bozkurt A; Yildiray-Sahin D; Unal I; Acartürk E
    Cardiol J; 2009; 16(1):43-9. PubMed ID: 19130415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac resynchronization therapy in pacemaker-dependent patients with left ventricular dysfunction.
    Gierula J; Cubbon RM; Jamil HA; Byrom R; Baxter PD; Pavitt S; Gilthorpe MS; Hewison J; Kearney MT; Witte KK
    Europace; 2013 Nov; 15(11):1609-14. PubMed ID: 23736807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The level of NT-proBNP in ambulatory patients with chronic heart failure with preserved ejection fraction of the left ventricle.
    Kirillova VV; Sokolova LA; Meshchaninov VN; Pershanova VI
    Ter Arkh; 2018 Sep; 90(9):68-72. PubMed ID: 30701738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multicenter, randomized, double-blind, parallel-group, placebo-controlled study of the effects of qili qiangxin capsules in patients with chronic heart failure.
    Li X; Zhang J; Huang J; Ma A; Yang J; Li W; Wu Z; Yao C; Zhang Y; Yao W; Zhang B; Gao R;
    J Am Coll Cardiol; 2013 Sep; 62(12):1065-1072. PubMed ID: 23747768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diagnostic value of plasma concentration of pro-brain natriuretic peptide in congestive heart failure in pediatric patients with ventricular septal defects].
    Wu YR; Chen SB; Huang MR; Zhang YQ; Sun K; Chen S
    Zhonghua Er Ke Za Zhi; 2005 Mar; 43(3):161-4. PubMed ID: 15833183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-terminal pro-brain natriuretic peptide and exercise capacity in chronic heart failure: data from the Heart Failure and a Controlled Trial Investigating Outcomes of Exercise Training (HF-ACTION) study.
    Felker GM; Whellan D; Kraus WE; Clare R; Zannad F; Donahue M; Adams K; McKelvie R; Piña IL; O'Connor CM;
    Am Heart J; 2009 Oct; 158(4 Suppl):S37-44. PubMed ID: 19782787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No effect of group-based aerobic interval training on N-terminal pro- B-type natriuretic peptide levels in patients with chronic heart failure.
    Nilsson BB; Westheim A; Risberg MA; Arnesen H; Seljeflot I
    Scand Cardiovasc J; 2010 Aug; 44(4):223-9. PubMed ID: 20636229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma amino-terminal pro-brain natriuretic peptide: a novel approach to the diagnosis of cardiac dysfunction.
    Campbell DJ; Mitchelhill KI; Schlicht SM; Booth RJ
    J Card Fail; 2000 Jun; 6(2):130-9. PubMed ID: 10908087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of a Higher Heart Rate on Quality of Life and Functional Capacity in Patients With Left Ventricular Diastolic Dysfunction.
    Wahlberg K; Arnold ME; Lustgarten D; Meyer M
    Am J Cardiol; 2019 Oct; 124(7):1069-1075. PubMed ID: 31395299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency.
    Toblli JE; Lombraña A; Duarte P; Di Gennaro F
    J Am Coll Cardiol; 2007 Oct; 50(17):1657-65. PubMed ID: 17950147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term results of intensified, N-terminal-pro-B-type natriuretic peptide-guided versus symptom-guided treatment in elderly patients with heart failure: five-year follow-up from TIME-CHF.
    Sanders-van Wijk S; Maeder MT; Nietlispach F; Rickli H; Estlinbaum W; Erne P; Rickenbacher P; Peter M; Pfisterer MP; Brunner-La Rocca HP;
    Circ Heart Fail; 2014 Jan; 7(1):131-9. PubMed ID: 24352403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of ejection fraction on N-terminal ProBNP and BNP levels in patients with acute CHF: analysis from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) study.
    O'Donoghue M; Chen A; Baggish AL; Anwaruddin S; Krauser DG; Tung R; Januzzi JL
    J Card Fail; 2005 Jun; 11(5 Suppl):S9-14. PubMed ID: 15948094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal evaluation of ventricular ejection fraction and NT-proBNP across heart failure subgroups.
    Martinsson A; Oest P; Wiborg MB; Reitan Ö; Smith JG
    Scand Cardiovasc J; 2018 Aug; 52(4):205-210. PubMed ID: 29656687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Impact of Sacrubitril/Valsartan on Clinical Treatment and hs-cTnT and NT-ProBNP Serum Levels and the Left Ventricular Function in Patients with Chronic Heart Failure.
    Gao Y; Xing C; Hao W; Zhao H; Wang L; Luan B; Hou A
    Int Heart J; 2020 Jan; 61(1):1-6. PubMed ID: 31875616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NT-pro-BNP during isotonic and isometric exercise in heart failure patients with preserved LV ejection fraction.
    Zdrenghea DT; Ilea M; Bodizs G; Sitar-Tăut A; Zdrenghea M; Pop D
    Clin Lab; 2014; 60(12):2055-61. PubMed ID: 25651741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.